Sodium ion channel mutations in glioblastoma patients correlate with shorter survival

av Joshi, Avadhut D, Parsons, D Williams, Velculescu, Victor E, Riggins, Gregory J
Publicerad 2011

Evaluation of Tyrosine Kinase Inhibitor Combinations for Glioblastoma Therapy

av Joshi, Avadhut D., Loilome, Watcharin, Siu, I-Mei, Tyler, Betty, Gallia, Gary L., Riggins, Gregory J.
Publicerad 2012

Role of CTLA4 in the Proliferation and Survival of Chronic Lymphocytic Leukemia

av Mittal, Amit K., Chaturvedi, Nagendra K., Rohlfsen, Rae A., Gupta, Payal, Joshi, Avadhut D., Hegde, Ganapati V., Bociek, R. Gregory, Joshi, Shantaram S.
Publicerad 2013

Synergistic and targeted therapy with a procaspase-3 activator and temozolomide extends survival in glioma rodent models and is feasible for the treatment of canine malignant gliom...

av Joshi, Avadhut D., Botham, Rachel C., Schlein, Lisa J., Roth, Howard S., Mangraviti, Antonella, Borodovsky, Alexandra, Tyler, Betty, Joslyn, Steve, Looper, Jayme S., Podell, Michael, Fan, Timothy M., Hergenrother, Paul J., Riggins, Gregory J.
I publikationen Oncotarget (2017)

Inhibition of glutaminase preferentially slows growth of glioma cells with mutant IDH1

av Seltzer, Meghan J., Bennett, Bryson D., Joshi, Avadhut D., Gao, Ping, Thomas, Ajit G., Ferraris, Dana V., Tsukamoto, Takashi, Rojas, Camilo J., Slusher, Barbara S., Rabinowitz, Joshua D., Dang, Chi V., Riggins, Gregory J.
Publicerad 2010

Mebendazole and temozolomide in patients with newly diagnosed high-grade gliomas: results of a phase 1 clinical trial

av Gallia, Gary L, Holdhoff, Matthias, Brem, Henry, Joshi, Avadhut D, Hann, Christine L, Bai, Ren-Yuan, Staedtke, Verena, Blakeley, Jaishri O, Sengupta, Soma, Jarrell, T Che, Wollett, Jessica, Szajna, Kelly, Helie, Nicole, Mattox, Austin K, Ye, Xiaobu, Rudek, Michelle A, Riggins, Gregory J
I publikationen Neurooncol Adv (2020)